333 related articles for article (PubMed ID: 25926654)
1. Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K-Related Sequences.
Contreras-Galindo R; Kaplan MH; Dube D; Gonzalez-Hernandez MJ; Chan S; Meng F; Dai M; Omenn GS; Gitlin SD; Markovitz DM
J Virol; 2015 Jul; 89(14):7187-201. PubMed ID: 25926654
[TBL] [Abstract][Full Text] [Related]
2. Genomic flexibility of human endogenous retrovirus type K.
Dube D; Contreras-Galindo R; He S; King SR; Gonzalez-Hernandez MJ; Gitlin SD; Kaplan MH; Markovitz DM
J Virol; 2014 Sep; 88(17):9673-82. PubMed ID: 24920813
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of Human Endogenous Retrovirus Type K to Reverse Transcriptase Inhibitors.
Contreras-Galindo R; Dube D; Fujinaga K; Kaplan MH; Markovitz DM
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931682
[TBL] [Abstract][Full Text] [Related]
4. Reconstitution of an infectious human endogenous retrovirus.
Lee YN; Bieniasz PD
PLoS Pathog; 2007 Jan; 3(1):e10. PubMed ID: 17257061
[TBL] [Abstract][Full Text] [Related]
5. Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells.
Patience C; Takeuchi Y; Cosset FL; Weiss RA
J Virol; 1998 Apr; 72(4):2671-6. PubMed ID: 9525584
[TBL] [Abstract][Full Text] [Related]
6. Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals.
Contreras-Galindo R; Kaplan MH; Contreras-Galindo AC; Gonzalez-Hernandez MJ; Ferlenghi I; Giusti F; Lorenzo E; Gitlin SD; Dosik MH; Yamamura Y; Markovitz DM
J Virol; 2012 Jan; 86(1):262-76. PubMed ID: 22031938
[TBL] [Abstract][Full Text] [Related]
7. Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles.
Boller K; Schönfeld K; Lischer S; Fischer N; Hoffmann A; Kurth R; Tönjes RR
J Gen Virol; 2008 Feb; 89(Pt 2):567-572. PubMed ID: 18198388
[TBL] [Abstract][Full Text] [Related]
8. Human endogenous retrovirus family HERV-K(HML-2) RNA transcripts are selectively packaged into retroviral particles produced by the human germ cell tumor line Tera-1 and originate mainly from a provirus on chromosome 22q11.21.
Ruprecht K; Ferreira H; Flockerzi A; Wahl S; Sauter M; Mayer J; Mueller-Lantzsch N
J Virol; 2008 Oct; 82(20):10008-16. PubMed ID: 18684837
[TBL] [Abstract][Full Text] [Related]
9. A Comprehensive Analysis of Human Endogenous Retroviruses HERV-K (HML.2) from Teratocarcinoma Cell Lines and Detection of Viral Cargo in Microvesicles.
Morozov VA; Morozov AV
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830279
[TBL] [Abstract][Full Text] [Related]
10. Infectious Entry Pathway Mediated by the Human Endogenous Retrovirus K Envelope Protein.
Robinson LR; Whelan SP
J Virol; 2016 Jan; 90(7):3640-9. PubMed ID: 26792739
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 Infection of Primary CD4
Young GR; Terry SN; Manganaro L; Cuesta-Dominguez A; Deikus G; Bernal-Rubio D; Campisi L; Fernandez-Sesma A; Sebra R; Simon V; Mulder LCF
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046457
[TBL] [Abstract][Full Text] [Related]
12. MuLV packaging systems as models for estimating/measuring retrovirus recombination frequency.
Patience C; Takeuch Y; Cosset FL; Weiss RA
Dev Biol (Basel); 2001; 106():169-79; discussion 253-63. PubMed ID: 11761229
[TBL] [Abstract][Full Text] [Related]
13. Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer.
Contreras-Galindo R; Kaplan MH; Leissner P; Verjat T; Ferlenghi I; Bagnoli F; Giusti F; Dosik MH; Hayes DF; Gitlin SD; Markovitz DM
J Virol; 2008 Oct; 82(19):9329-36. PubMed ID: 18632860
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 interacts with human endogenous retrovirus K (HML-2) envelopes derived from human primary lymphocytes.
Brinzevich D; Young GR; Sebra R; Ayllon J; Maio SM; Deikus G; Chen BK; Fernandez-Sesma A; Simon V; Mulder LC
J Virol; 2014 Jun; 88(11):6213-23. PubMed ID: 24648457
[TBL] [Abstract][Full Text] [Related]
15. Packaging of human endogenous retrovirus sequences is undetectable in porcine endogenous retrovirus particles produced from human cells.
Suling K; Quinn G; Wood J; Patience C
Virology; 2003 Aug; 312(2):330-6. PubMed ID: 12919738
[TBL] [Abstract][Full Text] [Related]
16. Human Endogenous Retrovirus-K HML-2 integration within
Karamitros T; Hurst T; Marchi E; Karamichali E; Georgopoulou U; Mentis A; Riepsaame J; Lin A; Paraskevis D; Hatzakis A; McLauchlan J; Katzourakis A; Magiorkinis G
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10434-10439. PubMed ID: 30249655
[TBL] [Abstract][Full Text] [Related]
17. Modulation of human endogenous retrovirus (HERV) transcription during persistent and de novo HIV-1 infection.
Vincendeau M; Göttesdorfer I; Schreml JM; Wetie AG; Mayer J; Greenwood AD; Helfer M; Kramer S; Seifarth W; Hadian K; Brack-Werner R; Leib-Mösch C
Retrovirology; 2015 Mar; 12():27. PubMed ID: 25886562
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production.
Bhardwaj N; Maldarelli F; Mellors J; Coffin JM
J Virol; 2014 Oct; 88(19):11108-20. PubMed ID: 25056891
[TBL] [Abstract][Full Text] [Related]
19. The HERV-K accessory protein Np9 controls viability and migration of teratocarcinoma cells.
Chan SM; Sapir T; Park SS; Rual JF; Contreras-Galindo R; Reiner O; Markovitz DM
PLoS One; 2019; 14(2):e0212970. PubMed ID: 30818388
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein.
Gonzalez-Hernandez MJ; Cavalcoli JD; Sartor MA; Contreras-Galindo R; Meng F; Dai M; Dube D; Saha AK; Gitlin SD; Omenn GS; Kaplan MH; Markovitz DM
J Virol; 2014 Aug; 88(16):8924-35. PubMed ID: 24872592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
